ReviewTranslational lung cancer research2018

Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?

Simon Heeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.